AU4289899A - Novel physiologically active substances inhibiting the proliferation of human immunodeficiency virus (hiv) - Google Patents
Novel physiologically active substances inhibiting the proliferation of human immunodeficiency virus (hiv)Info
- Publication number
- AU4289899A AU4289899A AU42898/99A AU4289899A AU4289899A AU 4289899 A AU4289899 A AU 4289899A AU 42898/99 A AU42898/99 A AU 42898/99A AU 4289899 A AU4289899 A AU 4289899A AU 4289899 A AU4289899 A AU 4289899A
- Authority
- AU
- Australia
- Prior art keywords
- hiv
- proliferation
- active substances
- immunodeficiency virus
- human immunodeficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10/181799 | 1998-06-29 | ||
| JP18179998 | 1998-06-29 | ||
| PCT/JP1999/003428 WO2000000631A1 (en) | 1998-06-29 | 1999-06-25 | Novel physiologically active substances inhibiting the proliferation of human immunodeficiency virus (hiv) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4289899A true AU4289899A (en) | 2000-01-17 |
Family
ID=16107066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU42898/99A Abandoned AU4289899A (en) | 1998-06-29 | 1999-06-25 | Novel physiologically active substances inhibiting the proliferation of human immunodeficiency virus (hiv) |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP3875024B2 (en) |
| AU (1) | AU4289899A (en) |
| WO (1) | WO2000000631A1 (en) |
-
1999
- 1999-06-25 AU AU42898/99A patent/AU4289899A/en not_active Abandoned
- 1999-06-25 WO PCT/JP1999/003428 patent/WO2000000631A1/en active Application Filing
- 1999-06-25 JP JP2000557384A patent/JP3875024B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3875024B2 (en) | 2007-01-31 |
| WO2000000631A1 (en) | 2000-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5726694A (en) | Human immunodeficiency virus decoy | |
| IL143512A (en) | Azabicycloalkanes, pharmaceutical compositions comprising same and use thereof for the manufacture of medicaments for the prevention or treatment of infection by immunodeficiency virus | |
| AU7305594A (en) | Physiologically active substance-prolonged releasing-type pharmaceutical preparation | |
| PL344223A1 (en) | Compositions for the treatment of hiv and other viral infections | |
| AU2265701A (en) | Anti-hiv-1 conjugates for treatment of hiv disease | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| AU1224100A (en) | Reference clones and sequences for non-subtype b isolates of human immunodeficiency virus type 1 | |
| AU1067599A (en) | Peptide compositions for the treatment and prevention of hiv infection | |
| AU9186598A (en) | Killer t cell receptor recognizing human immunodeficiency virus | |
| AU4088697A (en) | Postinfection human immunodeficiency virus (hiv) vaccination therapy | |
| HUP0200841A2 (en) | Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein | |
| HK1046428A1 (en) | The genome of the hiv-1 inter-subtype (c/b') and use thereof | |
| AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
| AU1463992A (en) | Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus | |
| NZ307494A (en) | Lymphokine capable of inhibiting immunodeficiency viruses | |
| AU5848794A (en) | Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use | |
| AU2281601A (en) | Treatment of viral infections using levovirinTM | |
| AU6445798A (en) | Feline immunodeficiency virus clone jsy3 | |
| AU2960000A (en) | Detection of human immunodeficiency virus | |
| AU4289899A (en) | Novel physiologically active substances inhibiting the proliferation of human immunodeficiency virus (hiv) | |
| AU2597599A (en) | The use of hiv-1 integrase in screening hiv-1 drug candidates | |
| AU3538699A (en) | Novel physiologically active substances | |
| AU5494298A (en) | Pharmaceutical compositions for the treatment of the eye | |
| AU1189899A (en) | Inhibition of human immunodeficiency virus (hiv-1) replication | |
| AU8096998A (en) | Attenuated human immunodeficiency virus vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |